Activation barriers to structural transition determine deposition rates of Alzheimer's disease Aβ amyloid

Journal of Structural Biology

Volumn 130, Issue 2-3, 2000, Pages 174-183

  Esler, William P ^a   Felix, Arthur M ^b   Stimson, Evelyn R ^a   Lachenmann, Marcel J ^c   Ghilardi, Joseph R ^d   Lu, Yi An ^f   Vinters, Harry V ^e   Mantyh, Patrick W ^d   Lee, Jonathan P ^g   Maggio, John E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b RAMAPO COLLEGE OF NEW JERSEY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UCLA MEDICAL CENTER   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Boston University ^*  (United States)

Author keywords

Alzheimer's disease; Amyloid; A ; Deposition; Peptide conformation

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AUTORADIOGRAPHY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN CONFORMATION; SOLUBILITY;

EID: 0033863220     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.2000.4276     Document Type: Article

References (41)

1. Solid phase peptide synthesis
2. Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register
3. Hereditary cerebral hemorrhage with amyloidosis - Dutch type (HCHWA-D). I. A review of clinical, radiologic and genetic aspects
4. Pathologic conformations of prion proteins
5. Stereochemical specificity of Alzheimer's disease beta-peptide assembly
6. A beta deposition inhibitor screen using synthetic amyloid
7. Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence
8. In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics
9. Alzheimer's disease amyloid propagation by a template dependent dock-lock mechanism
10. Deposition of soluble Amyloid-beta onto amyloid templates: With application for the identification of amyloid fibril extension inhibitors
11. The consortium to establish a registry for Alzheimer's disease (CERAD). X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease
12. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
13. Molecular determinants of amyloid deposition in Alzheimer's disease: Conformational studies of synthetic beta-protein fragments
14. Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: Analysis by x-ray diffraction
15. Refined fibril structures: The hydrophobic core in Alzheimer's amyloid beta-protein and prion as revealed by X-ray diffraction
16. Diagnosis of Alzheimer's disease
17. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation
18. Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro
19. Temperature dependence of amyloid beta-protein fibrillization
20. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide
21. 1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence
22. The monomeric Aβ peptide in water: Mechanistic implications for Alzheimer's disease
23. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type
24. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D). II. A review of histopathological aspects
25. Brain amyloid - A physicochemical perspective
26. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide
27. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques
28. Solid phase synthesis without repetitive acidolysis. Preparation of leucyl-alanyl-glycyl-valine using 9-fluorenylmethyloxycarbonylamino acids
29. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro
30. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains
31. Alzheimer's disease: A central role for amyloid
32. Alzheimer's disease: Genotypes, phenotypes, and treatments
33. Deposition of monomeric, not oligomeric, Aβ mediates growth of Alzheimer's disease plaques in human brain preparations in vitro
34. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D)
35. Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy
36. For protein misassembly, it's the 'I' decade
37. Chemical shifts as a tool for structure determination
38. The chemical shift index: A fast and simple method for the assignment of protein secondary structure through NMR spectroscopy
39. Residual structure in the Alzheimer's disease peptide: Probing the origin of a central hydrophobic cluster
40. 2H-labeled Glu/Asp: Application to pK(a) measurements in Aβ amyloid peptides